Integral Ad Science (NASDAQ:IAS) Raised to Buy at Wall Street Zen

Integral Ad Science (NASDAQ:IAS - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued on Saturday.

Several other equities analysts also recently issued reports on the stock. Truist Financial upped their price objective on shares of Integral Ad Science from $16.00 to $17.00 and gave the company a "buy" rating in a report on Monday, March 3rd. Scotiabank assumed coverage on shares of Integral Ad Science in a report on Friday, February 28th. They set a "sector perform" rating and a $12.00 price objective on the stock. Morgan Stanley cut their price objective on shares of Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating on the stock in a report on Thursday, April 17th. Stifel Nicolaus cut their price target on shares of Integral Ad Science from $15.00 to $13.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Finally, Robert W. Baird restated a "neutral" rating and set a $9.00 price objective (down from $16.00) on shares of Integral Ad Science in a research note on Friday, March 28th. Six investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $13.55.

Integral Ad Science Stock Down 1.3%

Shares of IAS stock traded down $0.11 during mid-day trading on Friday, hitting $8.22. 708,473 shares of the stock traded hands, compared to its average volume of 995,606. Integral Ad Science has a 52-week low of $6.26 and a 52-week high of $13.62. The company has a debt-to-equity ratio of 0.01, a current ratio of 4.01 and a quick ratio of 4.01. The stock has a market cap of $1.36 billion, a P/E ratio of 28.34, a P/E/G ratio of 1.42 and a beta of 1.59. The stock's fifty day moving average is $7.58 and its two-hundred day moving average is $9.10.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings data on Monday, May 12th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.02. Integral Ad Science had a net margin of 8.56% and a return on equity of 4.74%. The firm had revenue of $134.07 million for the quarter, compared to the consensus estimate of $129.20 million. Equities analysts predict that Integral Ad Science will post 0.26 EPS for the current year.

Insider Transactions at Integral Ad Science

In other news, CEO Lisa Utzschneider sold 8,367 shares of the stock in a transaction that occurred on Wednesday, May 7th. The stock was sold at an average price of $7.37, for a total transaction of $61,664.79. Following the transaction, the chief executive officer now owns 349,574 shares in the company, valued at $2,576,360.38. This trade represents a 2.34% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders have sold 86,222 shares of company stock valued at $636,252 in the last 90 days. 2.00% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in IAS. Alyeska Investment Group L.P. purchased a new position in shares of Integral Ad Science during the 4th quarter valued at approximately $41,543,000. Corvex Management LP purchased a new position in shares of Integral Ad Science during the 1st quarter valued at approximately $21,101,000. Nuveen LLC purchased a new position in shares of Integral Ad Science during the 1st quarter valued at approximately $10,897,000. Alta Fox Capital Management LLC lifted its position in shares of Integral Ad Science by 20,831.9% during the 1st quarter. Alta Fox Capital Management LLC now owns 1,214,053 shares of the company's stock valued at $9,785,000 after buying an additional 1,208,253 shares in the last quarter. Finally, Cubist Systematic Strategies LLC purchased a new position in shares of Integral Ad Science during the 1st quarter valued at approximately $7,441,000. Hedge funds and other institutional investors own 95.78% of the company's stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.